The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...

Adding a third oral medication early on in treatment may improve the effectiveness of standard-of-care treatment in patients ...

In a significant move to enhance public health and expand HIV prevention measures, Florida has recently enacted the “John W. Rheay Act” (Fla. Stat.